Authors: Bielicki JA, Clements M, Musiime V, Moore DP, Sidat M, Mulenga V, Mutata C, Nalwanga D, Waggie Z, Chilundo J, Chabala C, Bwakura-Dangarembizi M, Archary M, Kiggwe A, Dangor Z, Spittle B, Kapasa M, Tagoola A, Jeki C, Sacarlal J, Buck WC, Chanda S, Mujuru HA,...
Every year, millions of children are admitted to hospitals with severe pneumonia, mostly in resource-limited settings. Until now, standard international guidelines have required children to stay in the hospital for a full week of intravenous antibiotic treatment...
Authors: Nalwanga D, Clements M, Musiime V, Mulenga V, Mujuru AH, Sidat M, Buck WC, Madhi AS, Bielicki AJ, Moore PD, Walker S, Sharland M PediCAP trial team Published in: medRxiv (Preprint)
Published in The Journal of Pediatric Infectious Diseases, March 2022
On February 24th, 2022, the PediCAP consortium met for a general assembly meeting. The general assembly meeting is the main meeting in which all consortium members and work package leaders within the PediCAP project meet to share progress, address issues and make key...
At the end of 2021, LAB-Net provided training on the sampling and microbiology procedures to all five sites taking part in the microbiology sub-study in the Paediatric Community Acquired Pneumonia (PediCAP) project. Microbiologists, technicians and study...
WHO has launched a public call for comments on the draft of WHO Essential Medicines List Antibiotic Book. The book provides guidance on the prescribing and use of the antibiotics on the WHO Model List of Essential Medicines for over 30 common infections...
Every breath counts It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives that are lost daily to chest infections (pneumonia). According to...
Authors: Levine GA, Sharland M, Ellis S, Ferrisse Y, Loze C, Hsia Y, Fink G, Bielicki J; for the PediCAP project
Presented at: ECCMID 2021
The PediCAP health economics analysis team presented preliminary results of an analysis to estimate the global consumption and costs of two commonly used antibiotics for managing childhood infections in community settings: amoxicillin and co-amoxiclav. Both are...